Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Silibinin-C-2',3-dihydrogensuccinate, disodium salt

EU orphan designation number: EU/3/10/828   
Active ingredient: Silibinin-C-2',3-dihydrogensuccinate, disodium salt
Indication: Prevention of recurrent hepatitis C in liver transplant recipients
Sponsor: Rottapharm S.p.A
Galleria Unione, 5, 20122 Milan, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/12/2010 Orphan designation EMA/OD/103/10 (2010)9541 of 17/12/2010